| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |